APA (7th ed.) Citation

JS, L., AM, D., HJ, G., FB, T., O, B., DA, H., . . . EF, S. (2010). A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 16(11), 3078. https://doi.org/10.1158/1078-0432.CCR-09-3033

Chicago Style (17th ed.) Citation

JS, Lind, et al. "A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-naive Patients with Advanced Non-small Cell Lung Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 16, no. 11 (2010): 3078. https://doi.org/10.1158/1078-0432.CCR-09-3033.

MLA (9th ed.) Citation

JS, Lind, et al. "A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-naive Patients with Advanced Non-small Cell Lung Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 16, no. 11, 2010, p. 3078, https://doi.org/10.1158/1078-0432.CCR-09-3033.